Showing results (841-850 of 942) with videos related to
Sort By:
Pageof 95
Molecular Cancer Therapeutics|August 5, 2020
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage TrogocytosisSmruthi Vijayaraghavan, Lorraine Lipfert, Kristen Chevalier, et al.Plos Biology|July 28, 2022
Genome-wide functional analysis reveals key roles for kinesins in the mammalian and mosquito stages of the malaria parasite life cycleMohammad Zeeshan, Ravish Rashpa, David J P Ferguson, et al.Chest|February 13, 2016
Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk ScoreDavid C Hostler, Elizabeth S Marx, Lisa K Moores, et al.Chest|July 1, 2023
Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel ReportTatjana Potpara, Dominick J Angiolillo, Behnood Bikdeli, et al.International Wound Journal|July 21, 2009
V.A.C. Therapy in the management of paediatric wounds: clinical review and experienceMona Baharestani, Ibrahim Amjad, Kim Bookout, et al.Life Science Alliance|August 15, 2019
Kinesin-8B controls basal body function and flagellum formation and is key to malaria transmissionMohammad Zeeshan, David Jp Ferguson, Steven Abel, et al.JRSM Open|November 21, 2024
Providing personalised care for people with tuberculosis: an evaluation of enhanced case management in a UK TB Network 2013 to 2021Tim Crocker-Buque, Harry Hayden, Jacqui White, et al.Advanced Materials (Deerfield Beach, Fla.)|October 27, 2022
A Janus Au-Polymersome Heterostructure with Near-Field Enhancement Effect for Implant-Associated Infection PhototherapyChuanshuang Chen, Guangyu Chu, Wanting He, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activityC H Macphee, E R Appelbaum, K Johanson, et al.The Journal of Biological Chemistry|April 11, 2021
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and METJoost Neijssen, Rosa M F Cardoso, Kristen M Chevalier, et al.Pageof 95